Company Filing History:
Years Active: 2023
Title: Oliver Kayser - Innovator in Cannabinoid Biotechnology
Introduction
Oliver Kayser is a prominent inventor based in Dortmund, Germany. He has made significant contributions to the field of biotechnology, particularly in the production of cannabinoids. His innovative approach has the potential to impact various applications in medicine and industry.
Latest Patents
Oliver Kayser holds a patent for the biotechnological production of cannabinoids. This patent describes a method for the recombinant production of cannabigerolic acid in a host organism using a modified prenyltransferase. The patent also discloses a modified prenyltransferase, a nucleic acid molecule that codes for the modified prenyltransferase, and a recombinant organism that includes the modified prenyltransferase and/or the nucleic acid. He has 1 patent to his name.
Career Highlights
Oliver Kayser is affiliated with Technische Universität Dortmund, where he conducts research and develops innovative biotechnological methods. His work focuses on enhancing the efficiency and effectiveness of cannabinoid production, which is crucial for various therapeutic applications.
Collaborations
Oliver collaborates with Felix-Oliver Stehle, contributing to advancements in cannabinoid biotechnology. Their partnership exemplifies the importance of teamwork in driving innovation in scientific research.
Conclusion
Oliver Kayser is a key figure in the field of cannabinoid biotechnology, with a focus on innovative production methods. His contributions are paving the way for future advancements in this important area of research.